Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxegol placebo-controlled crossover study on reversal of codeine effects on colonic motility in healthy volunteers
2018-000013-20Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Mar 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of naloxegol and codeine + guaifenesin (2 arms), sponsored by KU Leuven. Started Mar 2018; status: completed.
02
Drugs
naloxegolcodeine + guaifenesin
Beyond the preview
Go deeper on 2018-000013-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000013-20.